07:55 AM EDT, 07/17/2025 (MT Newswires) -- Abbott Laboratories ( ABT ) reported Q2 adjusted earnings Thursday of $1.26 per diluted share, up from $1.14 a year earlier.

Analysts polled by FactSet expected $1.25.

Net sales for the quarter ended June 30 were $11.14 billion, compared with $10.38 billion a year earlier.

Analysts polled by FactSet expected $11.06 billion.

The company said it expects Q3 adjusted earnings of $1.28 to $1.32 per diluted share. Analysts polled by FactSet expect $1.34.

Abbott Laboratories ( ABT ) narrowed its 2025 adjusted earnings guidance to between $5.10 to $5.20 per diluted share, from the previous range of $5.05 to $5.25. Analysts polled by FactSet expect $5.16.

Shares of Abbott Laboratories ( ABT ) were down more than 5% in recent Thursday premarket activity.